Capricor Optimistic About Deramiocel In DMD Following CRL

 
• By Joseph Haas
  
Delay
Capricor may face delays but has an approval pathway in sight for its DMD cell therapy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cell Therapies

More from Advanced Therapies